Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

105 studies match

clinicaltrialsPublishedShowing 1–50 of 105 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06881784	Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)(RASolve 301)	recruiting	Phase 3	590	Revolution Medicines, Inc.INDUSTRY	19	Sep 29, 2026	clinicaltrials
NCT07011719	Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma	recruiting	Phase 3	720	Arcus Biosciences, Inc.INDUSTRY	17	Sep 29, 2026